Summary:
PlatinumRx’s successful funding round not only signifies a milestone for the startup but also heralds a new era of affordability and convenience in medication procurement, promising transformative benefits for patients across the nation.
In a significant boost to the healthcare landscape, Bangalore-based online pharmacy startup PlatinumRx has secured $800,000 in seed funding, led by India Quotient and a cohort of angel investors. This milestone marks a significant step forward for PlatinumRx as it strives to redefine accessibility and affordability in medication procurement.
PlatinumRx’s Funding Round Signals Healthcare Revolution
The funding injection serves as a catalyst for PlatinumRx’s expansion plans, particularly in enhancing its warehousing and distribution network. With a vision to transform chronic patient care, the startup aims to utilize a portion of the raised capital to broaden its geographical footprint across the country and diversify its range of products.
Founded by Ashutosh Pandey and Piyush Kumar, PlatinumRx stands out with its mission to revolutionize the way individuals with chronic conditions access essential medications. Through its innovative substitution engine, the startup empowers consumers to discover equivalent substitute medicines, ensuring potency, efficacy, and affordability remain uncompromised. By curating a selection of best-value substitutes from top brands like Cipla, Abbott, and Alkem, PlatinumRx endeavors to alleviate the financial burden associated with long-term medication needs.
Ashutosh Pandey and Piyush Kumar, Co-founders of PlatinumRx, expressed their excitement about partnering with India Quotient, highlighting the firm’s shared vision to democratize medication procurement for all Indians.
Gagan Goyal of India Quotient emphasized the pressing need for cost-effective solutions amidst the rise in chronic health conditions. He stressed the importance of scaling awareness to cater to a vast Total Addressable Market (TAM) and ease the financial strain on individuals managing chronic illnesses.
Also read: Indian Startups Raise $105M, Highlighting Innovation and Growth
With the raised capital, PlatinumRx aims to extend its reach to a broader spectrum of patients seeking affordable yet high-quality medications. Currently covering over 20,000 pin codes, with swift delivery services within two to three days and same-day delivery available in Bengaluru, PlatinumRx has also forged partnerships with old age homes and rehabilitation centers in Bengaluru, showcasing its commitment to reducing medical expenses for vulnerable populations.
Reports indicate a promising outlook for the online pharmacy market in India, with revenue projections reaching $453.30 million in 2024 and expected growth to approximately $649.50 million by 2028. This underscores the immense potential for innovation and accessibility in healthcare services.
PlatinumRx’s successful funding round not only signifies a milestone for the startup but also heralds a new era of affordability and convenience in medication procurement, promising transformative benefits for patients across the nation.
